• ashx
• ETF
• International Stocks
• China Stock

Xtrackers MSCI China A Inclusion Equity ETF

Expenses: 0.60% (Better than 1% of similar funds)

This is a bad choice for a China Stock International Stocks fund. See why »

• awp
• Mutual Fund
• Sector Equity
• Real Estate

Aberdeen Global Premier Property

Expenses: 1.37% (Better than 0% of similar funds)

This is a bad choice for a Real Estate Sector Equity fund. See why »

• basbx
• Mutual Fund
• Bond
• Total US Bond Market

Brown Advisory Sustainable Bond Fund Investor Shares

Expenses: 0.60% (Better than 1% of similar funds)

This is a bad choice for a Total US Bond Market Bond fund. See why »

• basix
• Mutual Fund
• Bond
• High Yield Bond

BlackRock Strategic Income Opportunities Portfolio Investor A Shares

Expenses: 1.03% (Better than 0% of similar funds)

This is a bad choice for a High Yield Bond Bond fund. See why »

• bawax
• Mutual Fund
• US Stocks
• Large Growth

Brown Advisory Sustainable Growth Fund Advisor Shares

Expenses: 1.13% (Better than 0% of similar funds)

This is a bad choice for a Large Growth US Stocks fund. See why »

• bemix
• Mutual Fund
• International Stocks
• Emerging Markets

Brandes Emerging Markets Value Fund Class I

Expenses: 1.12% (Better than 1% of similar funds)

This is a bad choice for a Emerging Markets International Stocks fund. See why »

• bgnax
• Mutual Fund
• Bond
• Government Bond

American Century Ginnie Mae Fund A Class

Expenses: 0.80% (Better than 0% of similar funds)

This is a bad choice for a Government Bond Bond fund. See why »

• bgrfx
• Mutual Fund
• US Stocks
• Mid-Cap Growth

Baron Growth Fund Retail Shares

Expenses: 1.29% (Better than 0% of similar funds)

This is a bad choice for a Mid-Cap Growth US Stocks fund. See why »

• biazx
• Mutual Fund
• Bond
• Government Bond

Brown Advisory Mortgage Securities Fund Investor Shares

Expenses: 0.52% (Better than 1% of similar funds)

This is a bad choice for a Government Bond Bond fund. See why »

• bib
• ETF
• Alternative
• Leveraged Equities

ProShares Ultra Nasdaq Biotechnology

Expenses: 0.95% (Better than 1% of similar funds)

This is a bad choice for a Leveraged Equities Alternative fund. See why »